Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
108.80
+0.58 (0.54%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Haemonetics Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Haemonetics stock has a consensus rating of "Buy" and an average price target of $106.4. The average 1-year stock price forecast is 2.21% lower than the current stock price, while the lowest is $86 (-20.96%) and the highest is $120 (+10.29%).
Price Target: $106.4 (-2.21%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Haemonetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 4 | 4 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Robert W. Baird | Robert W. Baird | Buy Maintains $96 → $119 | Buy | Maintains | $96 → $119 | +9.38% | Aug 21, 2026 |
| Barrington | Barrington | Buy Maintains $95 → $118 | Buy | Maintains | $95 → $118 | +8.46% | Aug 19, 2026 |
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 18, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $1 → $120 | Buy | Reiterates | $1 → $120 | +10.29% | Aug 18, 2026 |
| Citi | Citi | Hold Maintains $92 | Hold | Maintains | $92 | -15.44% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
1.41B
from 1.33B
Increased by 6.05%
Revenue Next Year
1.49B
from 1.41B
Increased by 5.25%
EPS This Year
5.30
from 4.96
Increased by 6.80%
EPS Next Year
5.74
from 5.30
Increased by 8.35%
EPS and Forward PE are based on non-GAAP adjusted numbers.